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Abstract  
The presence of adult pluripotent stem cells and the amazing regenerative capabilities 
make planarian flatworms an extraordinary experimental model to assess in vivo the 
effects of substances of both natural and synthetic origin on stem cell dynamics. This 
study focuses on the effects of chelidonine, an alkaloid obtained from Chelidonium 
majus. The expression levels of molecular markers specific for stem or differentiated 
cells were compared in chelidonine-treated and control planarians. The use of these 
markers demonstrates that chelidonine produces in vivo a significant anti-proliferative 
effect on planarian stem cells in a dose-dependent fashion. In response to chelidonine 
treatment mitotic abnormalities were also observed and the number of cells able to 
proceed to anaphase/telophase appeared significantly reduced with respect to the controls. 
Our results support the possibility that chelidonine acts on cell cycle progression by 
inhibition of tubulin polymerization. These studies provide a basis for preclinical 
evaluation in vivo of the effects of chelidonine on physiologically proliferating stem cells.  
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1. Introduction  
 
Stem cells are, by definition, undifferentiated cells that have both the ability to self-
renew, making identical copies at each division, and to differentiate specialized cells. 
These cells offer the possibility of a renewable source of replacement cells and tissues, 
with potential applications in regenerative medicine. However, a number of pathological 
conditions, such as cancer and psoriasis, are characterized by hyper-proliferative 
phenomena. Consequently, inhibition of cell proliferation results to be potentially useful 
in drug discovery to design agents targeted to the treatment of diseases characterized by 
uncontrolled or abnormal cellular proliferation. In this context, the so-called adult or 
somatic stem cells (ASCs) have attracted special attention. In vivo studies of ASCs are 
not easy in mammals due to the difficulty of developmental biology studies in vivo using 
vertebrate models. For this reason, most of the knowledge on ASC biology results from 
in vitro studies. Non-mammalian model systems can be alternatively used to assess in 
vivo the effect of substances on these cells.  
Planarians are an ideal animal model for in vivo analysis of ASCs. Their extraordinary 
ability to regenerate, as well as to sustain continuous homeostatic turnover of all 
differentiated cell types, relies on the presence of stem cells that share characteristics with 
the stem cells of higher organisms, including humans. Planarian regeneration involves 
remodeling of pre-existing tissues and formation of an outgrowth at wound region, in 
which the missing parts are newly formed (the regenerative blastema) (Gentile et al., 
2011; Slack, 2011). The discovery that planarian stem cells use evolutionarily conserved 
mechanisms that are surprisingly similar to the mechanisms we observe in mammalian 
stem cells, makes these invertebrates suitable to screen the effects of new drugs on stem 
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cells. In addition, the planarian genome shares a large number of genes with the human 
genome, including sequences involved in various aspects of human biology and disease.  
Our work focuses on the analysis of the effects produced in vivo by substances of natural 
origin, particularly a series of compounds contained in Chelidonium majus, on planarian 
stem cells. C. majus (greater celandine) is a herbaceous plant of the Papaveraceae family 
that spontaneously grows in temperate areas. As a starting point we studied the effects of 
chelidonine, an isoquinoline alkaloid derived from C. majus. The pharmacological 
potential of mitotic arrest by chelidonine is considered promising in cancer therapy. In 
this paper the activity of chelidonine was tested in vivo in Dugesia japonica, a clonal 
planarian strain widely used to study drug responsiveness (Kitamura et al., 2003; Nogi 
and Levin, 2005; Nogi et al., 2009). 
 
 
 
2. Materials and methods 
 
2.1. Animals and treatments  
Asexual specimens of D. japonica (GI strain) were maintained at 18°C in autoclaved  
stream water, fed weekly with chicken liver and starved one week before the 
experiments. Control groups were represented by planarians soaked in dimethylsulfoxide 
(DMSO) at different concentrations in the absence of drug and by untreated planarians, 
maintained in water. As literature data demonstrate that DMSO concentrations >0.1% 
should be avoided in order to be able to reliably observe any behavioral or toxic effects of 
hydrophobic drugs in these animals (Pagán et al., 2006; Yuan et al., 2011), we first 
analyzed the long-term effects of DMSO exposure before using it as a solubility-aiding 
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agent for chelidonine. Thirty planarians were exposed to DMSO in water at different 
concentrations (0.025%, 0.05%, 0.1%) or maintained in water (control group). The 
animals were exposed to these experimental conditions for a period of 7 days (long-term 
DMSO exposure). To assess the effects of DMSO during regeneration, thirty planarians 
were exposed to the same treatment, but were transected at the prepharyngeal region (Fig. 
1) after 1 day of exposure and left to regenerate in different concentrations of DMSO or 
in water. Chelidonine (Sigma) was freshly prepared in DMSO for each experiment, so 
that the final concentration of DMSO in water was 0.025%, 0.05% and 0.1% 
(corresponding to 5M chelidonine, 10M chelidonine and 20M chelidonine, 
respectively). Thirty intact worms of similar body size were exposed by soaking to the 
drug for 3-4 days. In another experimental protocol the animals were transected at the 
prepharyngeal region after 1 day of treatment and left to regenerate in presence of 
chelidonine or DMSO (control group). The fragments were sacrificed 3 or 6 days after 
cutting for successive experiments. In each protocol the solutions (30 ml) were changed 
daily.  
 
2.2 Preparation of dissociated cells  
Dissociated planarian cells were prepared according to Baguñà and Romero (1981) and 
stained with Hoechst 33342 DNA dye. A total of 10 l of cell suspension was used to 
calculate the number of metaphase cells versus anaphase/telophase cells. The number of 
mitotic figures was normalized to the number of total cells and the values are average ± 
s.d. of six independent samples, analyzed in duplicate for each experiment, assuming as 
100% the value of control planarians.  
 
 2.3. RNA isolation, reverse transcription and real time RT-PCR 
 6 
Total RNA was isolated using the Nucleospin RNAII kit (Macherey-Nagel), 
according to the manufacturer‟s instructions. Before cDNA synthesis, each extraction 
was tested for the absence of genomic DNA. cDNA was synthesized using GoTaq® 
2-step RT-qPCR system (Promega). For each experiment nine different RNA 
extractions were performed with three independent experimental groups. Each RNA 
sample was obtained from an experimental group including 6 different regenerating 
fragments (3 head fragments + 3 tail fragments). Real time RT-PCR was performed at 
least three times for each examined gene, using three replicates for each cDNA. 
SYBR Green chemistry-based RT-PCR was carried out on a Rotor-Gene 6000 Real 
time-PCR (Corbett Research). Details of the procedures are given in Table S1, 
according to the MIQE guidelines (Bustin et al., 2009). Preliminary experiments were 
performed to evaluate the transcriptional stability of candidate endogenous reference 
genes (Yuwen et al., 2010). Under our experimental conditions (0.025%, 0.05%, 0.1% 
DMSO), the stability of two planarian endogenous reference genes, D. japonica 
elongation factor-2 (DjEF2) and D. japonica β-actin (DjACTB) was analyzed using 
NormFinder software. DjEF2 was the most stable gene and for this reason it was 
selected as reference for comparative gene expression analysis. Expression levels of 
DjEF2 and DjACTB reference genes after DMSO treatments were analyzed by real 
time RT-PCR (Fig. S1). 
 
2.4. Statistics 
All values are presented as mean ± standard deviation (s.d.) of at least three different 
experiments in triplicate. Data tabulation and descriptive statistics were performed with 
Microsoft Excel. The statistical analysis was performed by means of non-parametric 
ANOVA Kruskal-Wallis test and Student‟s t-test (data not shown). According to Shapiro-
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Wilk test, the distribution of the logarithmically transformed data was not significantly 
different from that of a normal distribution. In addition, homoscedasticity analysis, 
determined with Hartley‟s F max test, revealed no differences in variability between the 
groups (in all samples the F max calculated was lower than the critical value at 0.05). For 
mitosis analysis, statistical significance was determined using the two-tailed unpaired 
Student‟s t-test. A value of P<0.05 was considered statistically significant. 
 
2.5. In situ hybridization  
Whole mount in situ hybridization was performed according to Umesono et al. (1997) 
with minor modifications (Nogi and Levin, 2005). DIG-labeled antisense riboprobe was 
synthesized by RNA polymerase (Roche), employing linearized Djmcm2 (cDNA: region 
168 to 761 bp) in pGEM-T Easy vector (Promega) as the template. 
 
3. Results  
 
3.1. Effects of chelidonine on tissue homeostasis and regeneration  
Under our experimental conditions, 20M chelidonine treatment resulted in abnormal 
phenotypes. On the contrary, no effects on mortality or gross abnormalities were 
observed in DMSO-treated planarians that appeared similar to the control group 
maintained in water. Most of the 20M chelidonine-treated planarians exhibited lesions 
and ventral curling (Fig. 2A-D). This phenotype, although consistent with a stress effect, 
strongly resembles the stereotypical stem cell-defective phenotype observed when stem 
cells are selectively eliminated by -irradiation or when animals are subjected to RNAi 
for genes required for stem cell function (Guo et al., 2006; Reddien et al., 2005). 
Chelidonine-induced phenotypes began to be detected around day 3. Some of them died 
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after the transfer in water, while others (about 80%) recovered a normal morphology in a 
few days. As these data suggest that 20M chelidonine interferes with proper stem cell 
function during tissue homeostasis, we also analyzed the effects during regeneration. 
When animals were transected after 1 day from the beginning of the treatment, 0.1% 
DMSO controls completely regenerated the missing body parts (Fig. 2E,F; Fig. S2A,B) 
while regeneration was severely impaired, or minimal blastemal tissue, often with 
blisters, was produced in chelidonine-treated fragments (Fig. 2G,H; Video S1 and Video 
S2). This phenotype was not dependent on which body part was regenerating, because a 
head that was regenerating a new tail, or a tail that was regenerating a new head, or a 
trunk regenerating both a head and a tail, showed similar defects (data not shown). 
Similar to that observed in intact animals, most chelidonine-treated fragments rescued 
regenerative capability after transfer in water. Further experiments with different 
chelidonine concentrations were performed. The 10M and 5M chelidonine treatment 
did not produce visible morphological alterations (data not shown). On the whole, these 
results indicate that the action of chelidonine is dose-dependent within the concentration 
range examined.  
 
3.2. Molecular analysis of planarian cells by assessment of potential changes in gene 
expression level 
Molecular analysis of stem cells and their descendants, as well as of specific cell types 
can be performed in planarians by gene expression analysis of different markers. We 
therefore examined the effects of chelidonine using Djmcm2, a planarian gene encoding 
an essential DNA replication factor, as a molecular marker for proliferating cells (Salvetti 
et al., 2000). This protein is a component of a complex - abundant in proliferating cells - 
that forms at the origins of replication during the initiation step of DNA replication and is 
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essential for ensuring that the process takes place only once for each cell cycle.  
Although whole mount in situ hybridization is not a quantitative method, our results 
showed a reduction of Djmcm2 hybridization signal in 20M chelidonine-treated 
planarians when compared to controls soaked in 0.1% DMSO (Fig. 3A-C). No 
morphological differences were detected between planarians soaked in DMSO 
(0.025%, 0.05%, 0.1%) and controls maintained in water. Both planarian fragments 
regenerated a blastema of similar size and showed comparable Djmcm2 expression 
pattern (Fig. S2A,B). To evaluate possible effects of long-term exposure to different 
DMSO concentrations on cell proliferation, Djmcm2 expression level was also 
investigated by real time RT-PCR in regenerating planarians. The level of Djmcm2 
transcripts after DMSO treatments was similar to that of the controls in water, 
indicating that this solvent does not significantly influence in vivo cell proliferation 
(Fig. S2C). The level of Djmcm2 expression after 20M chelidonine treatment was 
compared to 0.1% DMSO controls. A significant decrease of Djmcm2 expression 
level was observed. This result clearly demonstrates an anti-proliferative effect of 
chelidonine on planarian stem cells. Real time RT-PCR data showed that 5M 
chelidonine and 10M chelidonine did not cause any significant reduction of Djmcm2 
expression level (Fig. 4A-C). An ortholog of nanos, a gene required for maintenance 
of germ cell identity in diverse organisms, was also used as a specific marker to study 
the effect of 20M chelidonine on the germline stem cell subpopulation. Although 
primordial germ cells represent precursors of eggs and sperms in all sexually 
reproducing species, also asexual planarians express nanos and produce primordial 
germ cells, even if yet unknown mechanisms prevent these cells from developing into 
functional gametes (Handberg-Thorsager and Saló, 2007; Wang et al., 2007; Sato et 
al., 2006). Our results demonstrate that 20M chelidonine causes a significant 
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downregulation of the planarian nanos (Djnos) expression level (Fig. S3A). This 
result implies that the overall stem cell system (the sole cells with proliferative 
capability in planarians) is a selective target of the drug. To support this possibility, 
the change in expression level of Djinx-11, a marker of committed progenitors, has 
been analyzed by real time RT-PCR. Djinx-11 gene encodes a planarian stem cell gap 
junction protein required for the movement of small molecules that control 
maintenance, migration and differentiation of the progeny of proliferative cells 
(Oviedo and Levin, 2007). The expression level of this gene did not significantly 
change after chelidonine treatments (Fig. 4D-F). To evaluate possible cytotoxic side 
effects of this alkaloid to postmitotic cells, another member of the innexin gene 
family, Djinx1, whose expression is limited to the intestine, was examined (Oviedo 
and Levin, 2007). Djsyt, a planarian gene encoding synaptotagmin, a protein involved 
in the regulation of synaptic and extra-synaptic membrane trafficking in the central 
nervous system, was also used as a marker specific for nerve cells. Our data show that 
chelidonine treatments do not affect the expression level of these genes (Fig. S3B; 
Fig. 4G-I). On the whole, these results imply that chelidonine exposure causes no 
effects on differentiated cell types, such as intestinal or nerve cells.  
 
3.3 Chelidonine, at a concentration of 20μM, prevents cell cycle progression of stem cells 
To visualize in detail the effects of chelidonine on cell cycle and morphology of planarian 
cells, macerates (i.e. single cell types obtained by cell dissociation of worms: Baguñà and 
Romero, 1981) have been examined in specimens exposed to 20M chelidonine and 
compared to macerates of control planarians treated with 0.1% DMSO. Macerates from 
planarian head and tail fragments (3 days of regeneration) were used in order to 
maximize the number of mitotic figures in the samples. Chelidonine treatment affected 
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proliferating cells, resulting in abnormal metaphase and anaphase/telophase figures, as 
visualized by counterstaining with Hoechst 33342 in Fig. 5A-F. Treated interphase cells 
were unaffected (data not shown). To assess the possibility that cells exposed to 
chelidonine do not progress in the cell cycle, the percentage of metaphase and 
anaphase/telophase figures has been compared in macerates obtained from both 
chelidonine-treated and DMSO control planarians. As shown in Fig. 5G the percentage of 
cycling cells, able to proceeds to anaphase/telophase, appeared significantly reduced in 
planarians treated with chelidonine with respect to the controls. Under the anti-
proliferative effect of chelidonine, in fact, the percentage of metaphase figures, calculated 
by the analysis of the ratio between metaphases and anaphases/telophases in 0.1% DMSO 
controls and 20M chelidonine, resulted significantly higher in the treated specimens that 
in the controls. The simplest explanation of these results is that a number of cycling cells 
remain arrested at metaphase.  
 
4. Discussion  
 
In this work, we demonstrate the anti-proliferative effect of chelidonine for the first time 
on stem cells in vivo, using planarians as an animal model. Chelidonine is one of the 
principal alkaloids obtained from C. majus, a plant with a broad spectrum of 
pharmacological activities. Although chelidonine lacks DNA-binding capacity, this 
alkaloid possesses significant anti-proliferative effects, and has the ability to arrest cell 
growth in different cell lines. These results support the possibility that chelidonine is an 
effective anticancer drug (Kaminskyy et al., 2008; Philchenkov et al., 2008). Different 
mechanisms have been proposed to explain the properties of this drug. Inhibition of 
telomerase activity and apoptosis stimulation has been described in primary human uveal 
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melanoma cells (Kemény-Beke et al., 2006; Noureini and Wink, 2009). Literature data 
also demonstrate that chelidonine blocks mitosis by inhibition of tubulin polymerization 
and activation of the stress activated protein kinase/Jun kinase pathway (Panzer et al., 
2001; Wolff and Knipling, 1993). Although these effects have been proved in different 
cell lines, no data are available on stem cells in vivo. Planarians are highly plastic animals 
(Gentile et al., 2011; Wagner et al., 2011). During regeneration planarian stem cells 
activate an intense proliferative program to restore the lost body parts. The presence of 
two distinct cellular compartments (a proliferative compartment and a functional, 
postmitotic compartment), as well as the use of cell-specific markers, makes regeneration 
a unique experimental model to predict drug-induced effects on single cell types. We 
have demonstrated that 20M chelidonine treatment causes morphological defects in 
these animals, and also prevents regeneration, mimicking the phenotypic effects produced 
by irradiation or functional ablation of stem cell genes (Guo et al., 2006; Reddien et al., 
2005). These results raise the possibility that chelidonine affects viability of stem cells. 
However, we observed that the chelidonine-induced effects were reversible, as most of 
the treated specimens recovered a normal morphology and regenerative capability after 
the transfer in water. This finding suggests that partial reduction in the number of stem 
cells occurred. Survived stem cells could then repopulate the body of the animals in a 
short time (Salvetti et al., 2009, Wagner et al., 2011). Our results support the possibility 
that this alkaloid blocks cell proliferation with limited cytotoxic effects (Kaminskyy et 
al., 2008). Although precise calibration of a drug concentration in vivo is difficult to 
achieve, especially when administered by soaking, we observed that the anti-proliferative 
effects of chelidonine depended on the applied dose. Anti-proliferative drugs are usually 
administered in vivo at a concentration required to completely halt the growth of target 
cells (total growth inhibition: TGI). The most effective treatment on planarians was 
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20M chelidonine. This value is comparable to chelidonine TGI on several tumor cell 
lines. A wide screening on 60 different tumor cell lines performed at NIH shows, in fact, 
a TGI for chelidonine of 20µM (Developmental Therapeutics Program NCI/NIH, website 
http://dtp.nci.nih.gov/dtpstandard/dwindex/index.jsp,  searching for “chelidonine” and 
selecting NCI60 Cancer Screen Current Data). 
In order to develop chelidonine to its full potential clinical applications, it is pivotal to 
obtain a clearer understanding of the molecular mechanisms that underlie its effects on 
stem cells in vivo. Because these studies are difficult in mammalian models, planarians 
and their pluripotent stem cells represent a suitable complementary system for dissecting 
relevant molecular details. We have followed a molecular strategy to analyze and link 
variation of gene expression with drug response of specific cell types. The use of 
molecular markers that characterize proliferating cells demonstrates that 20M 
chelidonine provokes a significant diminution in the expression level of these genes. Lack 
of side effects produced by DMSO long-term exposure has been proved by whole mount 
in situ hybridization and real time RT-PCR on regenerating planarians exposed to 
different DMSO concentrations (0.025%-0.1%) or maintained in water. On the whole the 
results demonstrate that DMSO i) does not cause morphological defects, ii) does not 
interfere with regenerative capability or with Djmcm2 expression and prove that the 
observed dose-effect is related to an increase in chelidonine concentrations and not in 
DMSO concentrations, suggesting that the effects of DMSO and chelidonine are not 
cumulative. It is important to point out that the effect of the drug extends to different stem 
cell subpopulations, as demonstrated by the significant decrease of the Djnos-positive 
germline stem cells in chelidonine-treated animals. These results provide evidence that 
20µM dose reduces significantly cell growth and affects germline stem cell viability. No 
effects were detected using markers generally employed to characterize differentiated cell 
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types, such as nerve or intestinal cells, suggesting that no generalized cytotoxic effect 
occurred. These results represent the first gene expression analysis in relation to 
chelidonine activity in vivo and reveal that the drug specifically affects dividing stem 
cells, whereas postmitotic cells are not influenced.  
We sought to understand how chelidonine interferes with the planarian stem cell system. 
Our data demonstrate that the effects of chelidonine on cell cycle progression may 
depend on inhibition of tubulin polymerization. A significant arrest of cells in the mitotic 
metaphase was observed as a consequence of chelidonine treatment. The inhibitory effect 
on dividing cells resulted in fact in abnormal accumulation of metaphase figures, while 
the incidence of anaphases/telophases consistently decreased. In addition, numerous 
anomalous mitotic cell forms could be observed. A chelidonine-mediated partial 
inactivation of the mitotic spindle, with consequent cytostatic effects on root tip cells (i.e. 
cells with stem-cell-like properties), has been described in Allium cepa (Krahulcová, 
1979). It is possible that this alkaloid acts at the colchicine-binding site, as it is a weak 
competitive inhibitor of colchicine binding (Wolff and Knipling, 1993). Even though 
these studies varied in methodology and sample, the results are remarkably consistent 
with our results, suggesting that the inhibitory effect of chelidonine on tubulin 
polymerization represents a major mechanism for growth arrest of dividing cells in vivo. 
The results of this research, according with previous studies on cell lines, support the idea 
that chelidonine represents an important anti-proliferative alkaloid devoid of significant 
cytotoxicity and emphasize the potential value of planarian stem cells in finding better 
drugs to treat human disease. 
 
5. Conclusions 
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To the best of our knowledge, this study is the first to report the effects of chelidonine on 
arrest of cell cycle in stem cells in vivo. Planarian model is also a rich source of 
information about the mechanisms of cell growth inhibition. Based on our data we 
hypothesize a mechanistic scenario that predicts how inhibition of tubulin polymerization 
plays a key role in the function of this drug. These findings provide new information to 
complete the understanding of the chelidonine anti-proliferative effects, and support the 
possible potential of this drug for the therapy of hyper-proliferative disorders, such as 
cancer and psoriasis. 
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Figure legends 
 
Figure 1. Schematic of amputation procedure of a planarian. Black line indicates the 
amputation level. Complete regeneration of the missing body parts occurs in about 10 
days at 18°C. Regenerated body parts are shown in light grey. ph: pharynx. 
 
Figure 2. Brightfield images of planarians after 20M chelidonine treatment. (A) 
Schematic representation of an intact planarian. (B) An intact control planarian 0.1% 
DMSO. (C) An intact planarian after 3 days of chelidonine treatment shows body lesions. 
(D) An intact planarian after 3 days of chelidonine treatment shows ventral curling. (E) 
Schematic representation of a planarian tail fragment regenerating a head. (F) A 0.1% 
DMSO control tail fragment regenerating a head, 3 days after amputation. (G) A tail 
fragment treated with chelidonine did not form regeneration blastema, 3 days after 
amputation. (H) A tail fragment treated with chelidonine shows a very reduced blastema 
with blisters, 3 days after amputation. Anterior is up. Dashed line in D and E corresponds 
to the original amputation site. Scale bar: 1 mm. 
 
Figure 3. In situ hybridization with Djmcm2 of planarian head fragments after 
20M chelidonine treatment. (A) Schematic representation of a planarian head 
fragment regenerating a tail. (B) A 0.1% DMSO control regenerating fragment shows 
strong hybridization signal, visualized as brown color by Nitro blue tetrazolium chloride/ 
5-Bromo-4-chloro-3-indolyl phosphate, toluidine salt (NBT/BCIP) chromogen 
precipitation in the mesenchymal tissue, where planarian stem cells are located. (C) A 
comparable fragment hybridized after chelidonine treatment shows reduced Djmcm2 
expression. Six days of regeneration. Anterior is up. Scale bar: 0.5 mm. 
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Figure 4. Expression level of Djmcm2, Djinx-11 and Djsyt analyzed in planarians 
after chelidonine treatment by real time RT- PCR. (A-C) Djmcm2 expression level. 
(A) 0.025% DMSO controls (DMSO)  and 5M chelidonine (CH). (B) 0.05% DMSO 
controls (DMSO) and 10M chelidonine (CH). (C) 0.1% DMSO controls (DMSO) and 
20M chelidonine (CH). (D-F) Djinx-11 expression level. (D) 0.025% DMSO controls 
(DMSO) and 5M chelidonine (CH). (E) 0.05% DMSO controls (DMSO) and 10M 
chelidonine (CH). (F) 0.1% DMSO controls (DMSO) and 20M chelidonine (CH). (G-I) 
Djsyt expression level. (G) 0.025% DMSO controls (DMSO) and 5M chelidonine (CH). 
(H) 0.05% DMSO controls (DMSO) and 10M chelidonine (CH). (I) 0.1% DMSO 
controls (DMSO) and 20M chelidonine (CH). Expression levels are indicated in relative 
units, assuming a value of 1 for DMSO-treated controls. Samples were compared using 
the Kruskal-Wallis non-parametric ANOVA. **P<0.01. 
 
Figure 5: Mitotic abnormalities arise in vivo in response to 20M chelidonine 
treatment. 
 (A-C) Mitotic figures after 0.1% DMSO treatment (DMSO). (D-F) Mitotic figures after 
20M chelidonine treatment (CH). (A) Metaphase chromosomes appear arranged in the 
middle of the cell on the metaphase plate before being separated into each of the two 
daughter cells at the anaphase stage. (B) A cell at anaphase, usually defined as the 
separation of the sister chromatids by shortening of the microtubules of the mitotic 
spindle. (C) A telophase figure: both sets of chromosomes become now surrounded by 
new nuclei and unfold back into chromatin, while cytokinesis completes cell division. (D) 
A metaphase figure after chelidonine treatment. The chromosomes appear abnormally 
arranged in the cell. (E) An anaphase figure after chelidonine treatment, showing altered 
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chromosome separation. (F) A telophase figure after chelidonine treatment. In this cell 
cytokinesis did not occur to separate the daughter cells, resulting in a cell containing two 
condensed groups of chromosomes. Scale bar: 10 m. (G) Analysis of the ratio between 
metaphases and anaphases/telophases in 0.1% DMSO controls (DMSO) and 20M 
chelidonine (CH). Values are expressed as percentages with respect to controls, to which 
the arbitrary value of 100% has been assigned. Each value represents the mean ± standard 
deviation of six independent samples counted in duplicate. Samples were compared using 
t- test. **P<0.001. 
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Supporting information 
 
Figure S1: Expression levels of DjEF2 and DjACTB reference genes after DMSO 
treatment, analyzed by real time RT-PCR. (A) DjACTB. (B) DjEF2. Expression 
levels are indicated in relative units, assuming a value of 1 for water-treated controls.  
 
Figure S2. Effect of different DMSO concentrations, compared to water as a 
negative control. (A,B) Djmcm2 expression as visualized by situ hybridization of tail 
fragments regenerating a head, 6 days of regeneration. (A) A fragment maintained in 
water. (B) A fragment in 0.1% DMSO. Comparison of the obtained results 
demonstrates that both fragments regenerate normal heads and show similar Djmcm2 
expression. Dashed line in A and B corresponds to the original amputation site. (C) 
Expression level of Djmcm2 compared by real time RT-PCR in regenerating 
planarians (3 days of regeneration), exposed to different DMSO concentrations 
(0.025%-0.1%) or maintained in water. Expression levels are indicated in relative 
units, assuming a value of 1 for water-treated controls.  
 
Figure S3: Expression level of Djnos and Djinx1 analyzed in planarians after 
20M chelidonine treatment by real time RT-PCR. (A) Djnos expression level in 
chelidonine-treated planarians (CH) and 0.1%DMSO controls. (B) Djinx1 expression 
level in chelidonine-treated planarians (CH) and DMSO 0.1%controls. Expression 
levels are indicated in relative units, assuming a value of 1 for DMSO-treated 
controls. Samples were compared using the Kruskal-Wallis non-parametric ANOVA. 
*P<0.05. 
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Video S1: A representative example of a „curled‟ planarian fragment, as produced by 
20M chelidonine treatment. A small blastema, with a blister, is barely visible at the 
anterior region, 3 days after amputation (600 frames, 66.7 ms per frame). 
 
Video S2:  A representative example of a 0.1% DMSO regenerating control planarian 
is shown for comparison. Blastema is visible as a white area at the anterior region, 3 
days after amputation  (510 frames, 66.7 ms per frame). 
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Abstract  
The presence of adult pluripotent stem cells and the amazing regenerative capabilities 
make planarian flatworms an extraordinary experimental model to assess in vivo the 
effects of substances of both natural and synthetic origin on stem cell dynamics. This 
study focuses on the effects of chelidonine, an alkaloid obtained from Chelidonium 
majus. The expression levels of molecular markers specific for stem or differentiated 
cells were compared in chelidonine-treated and control planarians. The use of these 
markers demonstrates that chelidonine produces in vivo a significant anti-proliferative 
effect on planarian stem cells in a dose-dependent fashion. In response to chelidonine 
treatment mitotic abnormalities were also observed and the number of cells able to 
proceed to anaphase/telophase appeared significantly reduced with respect to the controls. 
Our results support the possibility that chelidonine acts on cell cycle progression by 
inhibition of tubulin polymerization. These studies provide a basis for preclinical 
evaluation in vivo of the effects of chelidonine on physiologically proliferating stem cells.  
 
Keywords: Chelidonine, Planarian, Stem Cells, Cell proliferation, Molecular Markers 
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1. Introduction  
 
Stem cells are, by definition, undifferentiated cells that have both the ability to self-
renew, making identical copies at each division, and to differentiate specialized cells. 
These cells offer the possibility of a renewable source of replacement cells and tissues, 
with potential applications in regenerative medicine. However, a number of pathological 
conditions, such as cancer and psoriasis, are characterized by hyper-proliferative 
phenomena. Consequently, inhibition of cell proliferation results to be potentially useful 
in drug discovery to design agents targeted to the treatment of diseases characterized by 
uncontrolled or abnormal cellular proliferation. In this context, the so-called adult or 
somatic stem cells (ASCs) have attracted special attention. In vivo studies of ASCs are 
not easy in mammals due to the difficulty of developmental biology studies in vivo using 
vertebrate models. For this reason, most of the knowledge on ASC biology results from 
in vitro studies. Non-mammalian model systems can be alternatively used to assess in 
vivo the effect of substances on these cells.  
Planarians are an ideal animal model for in vivo analysis of ASCs. Their extraordinary 
ability to regenerate, as well as to sustain continuous homeostatic turnover of all 
differentiated cell types, relies on the presence of stem cells that share characteristics with 
the stem cells of higher organisms, including humans. Planarian regeneration involves 
remodeling of pre-existing tissues and formation of an outgrowth at wound region, in 
which the missing parts are newly formed (the regenerative blastema) (Gentile et al., 
2011; Slack, 2011). The discovery that planarian stem cells use evolutionarily conserved 
mechanisms that are surprisingly similar to the mechanisms we observe in mammalian 
stem cells, makes these invertebrates suitable to screen the effects of new drugs on stem 
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cells. In addition, the planarian genome shares a large number of genes with the human 
genome, including sequences involved in various aspects of human biology and disease.  
Our work focuses on the analysis of the effects produced in vivo by substances of natural 
origin, particularly a series of compounds contained in Chelidonium majus, on planarian 
stem cells. C. majus (greater celandine) is a herbaceous plant of the Papaveraceae family 
that spontaneously grows in temperate areas. As a starting point we studied the effects of 
chelidonine, an isoquinoline alkaloid derived from C. majus. The pharmacological 
potential of mitotic arrest by chelidonine is considered promising in cancer therapy. In 
this paper the activity of chelidonine was tested in vivo in Dugesia japonica, a clonal 
planarian strain widely used to study drug responsiveness (Kitamura et al., 2003; Nogi 
and Levin, 2005; Nogi et al., 2009). 
 
 
 
2. Materials and methods 
 
2.1. Animals and treatments  
Asexual specimens of D. japonica (GI strain) were maintained at 18°C in autoclaved  
stream water, fed weekly with chicken liver and starved one week before the 
experiments. Control groups were represented by planarians soaked in dimethylsulfoxide 
(DMSO) at different concentrations in the absence of drug and by untreated planarians, 
maintained in water. As literature data demonstrate that DMSO concentrations >0.1% 
should be avoided in order to be able to reliably observe any behavioral or toxic effects of 
hydrophobic drugs in these animals (Pagán et al., 2006; Yuan et al., 2011), we first 
analyzed the long-term effects of DMSO exposure before using it as a solubility-aiding 
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agent for chelidonine. Thirty planarians were exposed to DMSO in water at different 
concentrations (0.025%, 0.05%, 0.1%) or maintained in water (control group). The 
animals were exposed to these experimental conditions for a period of 7 days (long-term 
DMSO exposure). To assess the effects of DMSO during regeneration, thirty planarians 
were exposed to the same treatment, but were transected at the prepharyngeal region (Fig. 
1) after 1 day of exposure and left to regenerate in different concentrations of DMSO or 
in water. Chelidonine (Sigma) was freshly prepared in DMSO for each experiment, so 
that the final concentration of DMSO in water was 0.025%, 0.05% and 0.1% 
(corresponding to 5M chelidonine, 10M chelidonine and 20M chelidonine, 
respectively). Thirty intact worms of similar body size were exposed by soaking to the 
drug for 3-4 days. In another experimental protocol the animals were transected at the 
prepharyngeal region after 1 day of treatment and left to regenerate in presence of 
chelidonine or DMSO (control group). The fragments were sacrificed 3 or 6 days after 
cutting for successive experiments. In each protocol the solutions (30 ml) were changed 
daily.  
 
2.2 Preparation of dissociated cells  
Dissociated planarian cells were prepared according to Baguñà and Romero (1981) and 
stained with Hoechst 33342 DNA dye. A total of 10 l of cell suspension was used to 
calculate the number of metaphase cells versus anaphase/telophase cells. The number of 
mitotic figures was normalized to the number of total cells and the values are average ± 
s.d. of six independent samples, analyzed in duplicate for each experiment, assuming as 
100% the value of control planarians.  
 
 2.3. RNA isolation, reverse transcription and real time RT-PCR 
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Total RNA was isolated using the Nucleospin RNAII kit (Macherey-Nagel), 
according to the manufacturer‟s instructions. Before cDNA synthesis, each extraction 
was tested for the absence of genomic DNA. cDNA was synthesized using GoTaq® 
2-step RT-qPCR system (Promega). For each experiment nine different  RNA 
extractions were performed with three independent experimental groups. Each RNA 
sample was obtained from an experimental group including 6 different regenerating 
fragments (3 head fragments + 3 tail fragments). Real time RT-PCR was performed at 
least three times for each examined gene, using three replicates for each cDNA. 
SYBR Green chemistry-based RT-PCR was carried out on a Rotor-Gene 6000 Real 
time-PCR (Corbett Research). Details of the procedures are given in Table S1, 
according to the MIQE guidelines (Bustin et al., 2009). Preliminary experiments were 
performed to evaluate the transcriptional stability of candidate endogenous reference 
genes (Yuwen et al., 2010). Under our experimental conditions (0.025%, 0.05%, 0.1% 
DMSO), the stability of two planarian endogenous reference genes, D. japonica 
elongation factor-2 (DjEF2) and D. japonica β-actin (DjACTB) was analyzed using 
NormFinder software. EF2 was the most stable gene and for this reason it was 
selected as reference for comparative gene expression analysis. Expression levels of 
DjEF2 and DjACTB reference genes after DMSO treatments were analyzed by real 
time RT-PCR (Fig. S1). 
 
2.4. Statistics 
All values are presented as mean ± standard deviation (s.d.) of at least three different 
experiments in triplicate. Data tabulation and descriptive statistics were performed with 
Microsoft Excel. The statistical analysis was performed by means of non-parametric 
ANOVA Kruskal-Wallis test. For mitosis analysis, statistical significance was determined 
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using the two-tailed unpaired Student‟s t-test. A value of P<0.05 was considered 
statistically significant. 
 
2.5. In situ hybridization  
Whole mount in situ hybridization was performed according to Umesono et al. (1997) 
with minor modifications (Nogi and Levin, 2005). DIG-labeled antisense riboprobe was 
synthesized by RNA polymerase (Roche), employing linearized Djmcm2 (cDNA: region 
168 to 761 bp) in pGEM-T Easy vector (Promega) as the template. 
 
3. Results  
 
3.1. Effects of chelidonine on tissue homeostasis and regeneration  
Under our experimental conditions, 20M chelidonine treatment resulted in abnormal 
phenotypes. On the contrary, no effects on mortality or gross abnormalities were 
observed in DMSO-treated planarians that appeared similar to the control group 
maintained in water. Most of the 20M chelidonine-treated planarians exhibited lesions 
and ventral curling (Fig. 2A-D). This phenotype, although consistent with a stress effect, 
strongly resembles the stereotypical stem cell-defective phenotype observed when stem 
cells are selectively eliminated by -irradiation or when animals are subjected to RNAi 
for genes required for stem cell function (Guo et al., 2006; Reddien et al., 2005). 
Chelidonine-induced phenotypes began to be detected around day 3. Some of them died 
after the transfer in water, while others (about 80%) recovered a normal morphology in a 
few days. As these data suggest that 20M chelidonine interferes with proper stem cell 
function during tissue homeostasis, we also analyzed the effects during regeneration. 
When animals were transected after 1 day from the beginning of the treatment, 0.1% 
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DMSO controls completely regenerated the missing body parts (Fig. 2E,F; Fig. S2A,B) 
while regeneration was severely impaired, or minimal blastemal tissue, often with 
blisters, was produced in chelidonine-treated fragments (Fig. 2G,H; Video S1 and Video 
S2). This phenotype was not dependent on which body part was regenerating, because a 
head that was regenerating a new tail, or a tail that was regenerating a new head, or a 
trunk regenerating both a head and a tail, showed similar defects (data not shown). 
Similar to that observed in intact animals, most chelidonine-treated fragments rescued 
regenerative capability after transfer in water. Further experiments with different 
chelidonine concentrations were performed. The 10M and 5M chelidonine treatment 
did not produce visible morphological alterations (data not shown). On the whole, these 
results indicate that the action of chelidonine is dose-dependent within the concentration 
range examined.  
 
 
3.2. Molecular analysis of planarian cells by assessment of potential changes in gene 
expression level 
Molecular analysis of stem cells and their descendants, as well as of specific cell types 
can be performed in planarians by gene expression analysis of different markers. We 
therefore examined the effects of chelidonine using Djmcm2, a planarian gene encoding 
an essential DNA replication factor, as a molecular marker for proliferating cells (Salvetti 
et al., 2000). This protein is a component of a complex - abundant in proliferating cells - 
that forms at the origins of replication during the initiation step of DNA replication and is 
essential for ensuring that the process takes place only once for each cell cycle.  
Although whole mount in situ hybridization is not a quantitative method, our results 
showed a reduction of Djmcm2 hybridization signal in 20M chelidonine-treated 
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planarians when compared to controls soaked in 0.1% DMSO (Fig. 3A-C). No 
morphological differences were detected between planarians soaked in DMSO 
(0.025%, 0.05%, 0.1%) and controls maintained in water. Both planarian fragments 
regenerated a blastema of similar size and showed comparable Djmcm2 expression 
pattern (Fig. S2A,B). To evaluate possible effects of long-term exposure to different 
DMSO concentrations on cell proliferation, Djmcm2 expression level was also 
investigated by real time RT-PCR in regenerating planarians. The level of Djmcm2 
transcripts after DMSO treatments was similar to that of the controls in water, 
indicating that this solvent does not significantly influence in vivo cell proliferation 
(Fig. S2C). The level of Djmcm2 expression after 20M chelidonine treatment was 
compared to 0.1% DMSO controls. A significant decrease of Djmcm2 expression 
level was observed. This result clearly demonstrates an anti-proliferative effect of 
chelidonine on planarian stem cells. Real time RT-PCR data showed that 5M 
chelidonine and 10M chelidonine did not cause any significant reduction of Djmcm2 
expression level (Fig. 4A-C). An ortholog of nanos, a gene required for maintenance 
of germ cell identity in diverse organisms, was also used as a specific marker to study 
the effect of 20M chelidonine on the germline stem cell subpopulation. Although 
primordial germ cells represent precursors of eggs and sperms in all sexually 
reproducing species, also asexual planarians express nanos and produce primordial 
germ cells, even if yet unknown mechanisms prevent these cells from developing into 
functional gametes (Handberg-Thorsager and Saló, 2007; Wang et al., 2007; Sato et 
al., 2006). Our results demonstrate that 20M chelidonine causes a significant 
downregulation of the planarian nanos (Djnos) expression level (Fig. S3A). This 
result implies that the overall stem cell system (the sole cells with proliferative 
capability in planarians) is a selective target of the drug. To support this possibility, 
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the change in expression level of Djinx-11, a marker of committed progenitors, has 
been analyzed by real time RT-PCR. Djinx-11 gene encodes a planarian stem cell gap 
junction protein required for the movement of small molecules that control 
maintenance, migration and differentiation of the progeny of proliferative cells 
(Oviedo and Levin, 2007). The expression level of this gene did not significantly 
change after chelidonine treatments (Fig. 4D-F). To evaluate possible cytotoxic side 
effects of this alkaloid to postmitotic cells, another member of the innexin gene 
family, Djinx1, whose expression is limited to the intestine, was examined (Oviedo 
and Levin, 2007). Djsyt, a planarian gene encoding synaptotagmin, a protein involved 
in the regulation of synaptic and extra-synaptic membrane trafficking in the central 
nervous system, was also used as a marker specific for nerve cells. Our data show that 
chelidonine treatments do not affect the expression level of these genes (Fig. S3B; 
Fig. 4G-I). On the whole, these results imply that chelidonine exposure causes no 
effects on differentiated cell types, such as intestinal or nerve cells.  
 
3.3 Chelidonine, at a concentration of 20μM, prevents cell cycle progression of stem cells 
To visualize in detail the effects of chelidonine on cell cycle and morphology of planarian 
cells, macerates (i.e. single cell types obtained by cell dissociation of worms: Baguñà and 
Romero, 1981) have been examined in specimens exposed to 20M chelidonine and 
compared to macerates of control planarians treated with 0.1% DMSO. Macerates from 
planarian head and tail fragments (3 days of regeneration) were used in order to 
maximize the number of mitotic figures in the samples. Chelidonine treatment affected 
proliferating cells, resulting in abnormal metaphase and anaphase/telophase figures, as 
visualized by counterstaining with Hoechst 33342 in Fig. 5A-F. Treated interphase cells 
were unaffected (data not shown). To assess the possibility that cells exposed to 
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chelidonine do not progress in the cell cycle, the percentage of metaphase and 
anaphase/telophase figures has been compared in macerates obtained from both 
chelidonine-treated and DMSO control planarians. As shown in Fig. 5G the percentage of 
cycling cells, able to proceeds to anaphase/telophase, appeared significantly reduced in 
planarians treated with chelidonine with respect to the controls. Under the anti-
proliferative effect of chelidonine, in fact, the percentage of metaphase figures, calculated 
by the analysis of the ratio between metaphases and anaphases/telophases in 0.1% DMSO 
controls and 20M chelidonine, resulted significantly higher in the treated specimens that 
in the controls. The simplest explanation of these results is that a number of cycling cells 
remain arrested at metaphase.  
 
4. Discussion  
 
In this work, we demonstrate the anti-proliferative effect of chelidonine for the first time 
on stem cells in vivo, using planarians as an animal model. Chelidonine is one of the 
principal alkaloids obtained from C. majus, a plant with a broad spectrum of 
pharmacological activities. Although chelidonine lacks DNA-binding capacity, this 
alkaloid possesses significant anti-proliferative effects, and has the ability to arrest cell 
growth in different cell lines. These results support the possibility that chelidonine is an 
effective anticancer drug (Kaminskyy et al., 2008; Philchenkov et al., 2008). Different 
mechanisms have been proposed to explain the properties of this drug. Inhibition of 
telomerase activity and apoptosis stimulation has been described in primary human uveal 
melanoma cells (Kemény-Beke et al., 2006; Noureini and Wink, 2009). Literature data 
also demonstrate that chelidonine blocks mitosis by inhibition of tubulin polymerization 
and activation of the stress activated protein kinase/Jun kinase pathway (Panzer et al., 
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2001; Wolff and Knipling, 1993). Although these effects have been proved in different 
cell lines, no data are available on stem cells in vivo. Planarians are highly plastic animals 
(Gentile et al., 2011; Wagner et al., 2011). During regeneration planarian stem cells 
activate an intense proliferative program to restore the lost body parts. The presence of 
two distinct cellular compartments (a proliferative compartment and a functional, 
postmitotic compartment), as well as the use of cell-specific markers, makes regeneration 
a unique experimental model to predict drug-induced effects on single cell types. We 
have demonstrated that 20M chelidonine treatment causes morphological defects in 
these animals, and also prevents regeneration, mimicking the phenotypic effects produced 
by irradiation or functional ablation of stem cell genes (Guo et al., 2006; Reddien et al., 
2005). These results raise the possibility that chelidonine affects viability of stem cells. 
However, we observed that the chelidonine-induced effects were reversible, as most of 
the treated specimens recovered a normal morphology and regenerative capability after 
the transfer in water. This finding suggests that partial reduction in the number of stem 
cells occurred. Survived stem cells could then repopulate the body of the animals in a 
short time (Salvetti et al., 2009, Wagner et al., 2011). Our results support the possibility 
that this alkaloid blocks cell proliferation with limited cytotoxic effects (Kaminskyy et 
al., 2008). Although precise calibration of a drug concentration in vivo is difficult to 
achieve, especially when administered by soaking, we observed that the anti-proliferative 
effects of chelidonine depended on the applied dose. Anti-proliferative drugs are usually 
administered in vivo at a concentration required to completely halt the growth of target 
cells (total growth inhibition: TGI). The most effective treatment on planarians was 
20M chelidonine. This value is comparable to chelidonine TGI on several tumor cell 
lines. A wide screening on 60 different tumor cell lines performed at NIH shows, in fact, 
a TGI for chelidonine of 20µM (Developmental Therapeutics Program NCI/NIH, website 
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http://dtp.nci.nih.gov/dtpstandard/dwindex/index.jsp,  searching for “chelidonine” and 
selecting NCI60 Cancer Screen Current Data). 
In order to develop chelidonine to its full potential clinical applications, it is pivotal to 
obtain a clearer understanding of the molecular mechanisms that underlie its effects on 
stem cells in vivo. Because these studies are difficult in mammalian models, planarians 
and their pluripotent stem cells represent a suitable complementary system for dissecting 
relevant molecular details. We have followed a molecular strategy to analyze and link 
variation of gene expression with drug response of specific cell types. The use of 
molecular markers that characterize proliferating cells demonstrates that 20M 
chelidonine provokes a significant diminution in the expression level of these genes. Lack 
of side effects produced by DMSO long-term exposure has been proved by whole mount 
in situ hybridization and real time RT-PCR on regenerating planarians exposed to 
different DMSO concentrations (0.025%-0.1%) or maintained in water. On the whole the 
results demonstrate that DMSO i) does not cause morphological defects, ii) does not 
interfere with regenerative capability or with Djmcm2 expression and prove that the 
observed dose-effect is related to an increase in chelidonine concentrations and not in 
DMSO concentrations, suggesting that the effects of DMSO and chelidonine are not 
cumulative. It is important to point out that the effect of the drug extends to different stem 
cell subpopulations, as demonstrated by the significant decrease of the Djnos-positive 
germline stem cells in chelidonine-treated animals. These results provide evidence that 
20µM dose reduces significantly cell growth and affects germline stem cell viability. No 
effects were detected using markers generally employed to characterize differentiated cell 
types, such as nerve or intestinal cells, suggesting that no generalized cytotoxic effect 
occurred. These results represent the first gene expression analysis in relation to 
chelidonine activity in vivo and reveal that the drug specifically affects dividing stem 
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cells, whereas postmitotic cells are not influenced.  
We sought to understand how chelidonine interferes with the planarian stem cell system. 
Our data demonstrate that the effects of chelidonine on cell cycle progression may 
depend on inhibition of tubulin polymerization. A significant arrest of cells in the mitotic 
metaphase was observed as a consequence of chelidonine treatment. The inhibitory effect 
on dividing cells resulted in fact in abnormal accumulation of metaphase figures, while 
the incidence of anaphases/telophases consistently decreased. In addition, numerous 
anomalous mitotic cell forms could be observed. A chelidonine-mediated partial 
inactivation of the mitotic spindle, with consequent cytostatic effects on root tip cells (i.e. 
cells with stem-cell-like properties), has been described in Allium cepa (Krahulcová, 
1979). It is possible that this alkaloid acts at the colchicine-binding site, as it is a weak 
competitive inhibitor of colchicine binding (Wolff and Knipling, 1993). Even though 
these studies varied in methodology and sample, the results are remarkably consistent 
with our results, suggesting that the inhibitory effect of chelidonine on tubulin 
polymerization represents a major mechanism for growth arrest of dividing cells in vivo. 
The results of this research, according with previous studies on cell lines, support the idea 
that chelidonine represents an important anti-proliferative alkaloid devoid of significant 
cytotoxicity and emphasize the potential value of planarian stem cells in finding better 
drugs to treat human disease. 
 
5. Conclusions 
 
To the best of our knowledge, this study is the first to report the effects of chelidonine on 
arrest of cell cycle in stem cells in vivo. Planarian model is also a rich source of 
information about the mechanisms of cell growth inhibition. Based on our data we 
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hypothesize a mechanistic scenario that predicts how inhibition of tubulin polymerization 
plays a key role in the function of this drug. These findings provide new information to 
complete the understanding of the chelidonine anti-proliferative effects, and support the 
possible potential of this drug for the therapy of hyper-proliferative disorders, such as 
cancer and psoriasis. 
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Figure legends 
 
Figure 1. Schematic of amputation procedure of a planarian. Black line indicates the 
amputation level. Complete regeneration of the missing body parts occurs in about 10 
days at 18°C. Regenerated body parts are shown in light grey. ph: pharynx. 
 
Figure 2. Brightfield images of planarians after 20M chelidonine treatment. (A) 
Schematic representation of an intact planarian. (B) An intact control planarian 0.1% 
DMSO. (C) An intact planarian after 3 days of chelidonine treatment shows body lesions. 
(D) An intact planarian after 3 days of chelidonine treatment shows ventral curling. (E) 
Schematic representation of a planarian tail fragment regenerating a head. (F) A 0.1% 
DMSO control tail fragment regenerating a head, 3 days after amputation. (G) A tail 
fragment treated with chelidonine did not form regeneration blastema, 3 days after 
amputation. (H) A tail fragment treated with chelidonine shows a very reduced blastema 
with blisters, 3 days after amputation. Anterior is up. Dashed line in D and E corresponds 
to the original amputation site. Scale bar: 1 mm. 
 
Figure 3. In situ hybridization with Djmcm2 of planarian head fragments after 
20M chelidonine treatment. (A) Schematic representation of a planarian head 
fragment regenerating a tail. (B) A 0.1% DMSO control regenerating fragment shows 
strong hybridization signal, visualized as brown color by Nitro blue tetrazolium chloride/ 
5-Bromo-4-chloro-3-indolyl phosphate, toluidine salt (NBT/BCIP) chromogen 
precipitation in the mesenchymal tissue, where planarian stem cells are located. (C) A 
comparable fragment hybridized after chelidonine treatment shows reduced Djmcm2 
expression. Six days of regeneration. Anterior is up. Scale bar: 0.5 mm. 
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Figure 4. Expression level of Djmcm2, Djinx-11 and Djsyt analyzed in planarians 
after chelidonine treatment by real time RT- PCR. (A-C) Djmcm2 expression level. 
(A) 0.025% DMSO controls (DMSO)  and 5M chelidonine (CH). (B) 0.05% DMSO 
controls (DMSO) and 10M chelidonine (CH). (C) 0.1% DMSO controls (DMSO) and 
20M chelidonine (CH). (D-F) Djinx-11 expression level. (D) 0.025% DMSO controls 
(DMSO) and 5M chelidonine (CH). (E) 0.05% DMSO controls (DMSO) and 10M 
chelidonine (CH). (F) 0.1% DMSO controls (DMSO) and 20M chelidonine (CH). (G-I) 
Djsyt expression level. (G) 0.025% DMSO controls (DMSO) and 5M chelidonine (CH). 
(H) 0.05% DMSO controls (DMSO) and 10M chelidonine (CH). (I) 0.1% DMSO 
controls (DMSO) and 20M chelidonine (CH). Expression levels are indicated in relative 
units, assuming a value of 1 for DMSO-treated controls. Samples were compared using 
the Kruskal-Wallis non-parametric ANOVA. **P<0.01. 
 
Figure 5: Mitotic abnormalities arise in vivo in response to 20M chelidonine 
treatment. 
 (A-C) Mitotic figures after 0.1% DMSO treatment (DMSO). (D-F) Mitotic figures after 
20M chelidonine treatment (CH). (A) Metaphase chromosomes appear arranged in the 
middle of the cell on the metaphase plate before being separated into each of the two 
daughter cells at the anaphase stage. (B) A cell at anaphase, usually defined as the 
separation of the sister chromatids by shortening of the microtubules of the mitotic 
spindle. (C) A telophase figure: both sets of chromosomes become now surrounded by 
new nuclei and unfold back into chromatin, while cytokinesis completes cell division. (D) 
A metaphase figure after chelidonine treatment. The chromosomes appear abnormally 
arranged in the cell. (E) An anaphase figure after chelidonine treatment, showing altered 
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chromosome separation. (F) A telophase figure after chelidonine treatment. In this cell 
cytokinesis did not occur to separate the daughter cells, resulting in a cell containing two 
condensed groups of chromosomes. Scale bar: 10 m. (G) Analysis of the ratio between 
metaphases and anaphases/telophases in 0.1% DMSO controls (DMSO) and 20M 
chelidonine (CH). Values are expressed as percentages with respect to controls, to which 
the arbitrary value of 100% has been assigned. Each value represents the mean ± standard 
deviation of six independent samples counted in duplicate. Samples were compared using 
t- test. **P<0.001. 
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Supporting information 
 
Figure S1: Expression levels of DjEF2 and DjACTB reference genes after DMSO 
treatment, analyzed by real time RT-PCR. (A) DjACTB. (B) DjEF2. Expression 
levels are indicated in relative units, assuming a value of 1 for water-treated controls.  
 
Figure S2. Effect of different DMSO concentrations, compared to water as a 
negative control. (A,B) Djmcm2 expression as visualized by situ hybridization of tail 
fragments regenerating a head, 6 days of regeneration. (A) A fragment maintained in 
water. (B) A fragment in 0.1% DMSO. Comparison of the obtained results 
demonstrates that both fragments regenerate normal heads and show similar Djmcm2 
expression. Dashed line in A and B corresponds to the original amputation site. (C) 
Expression level of Djmcm2 compared by real time RT-PCR in regenerating 
planarians (3 days of regeneration), exposed to different DMSO concentrations 
(0.025%-0.1%) or maintained in water. Expression levels are indicated in relative 
units, assuming a value of 1 for water-treated controls.  
 
Figure S3: Expression level of Djnos and Djinx1 analyzed in planarians after 
20M chelidonine treatment by real time RT-PCR. (A) Djnos expression level in 
chelidonine-treated planarians (CH) and 0.1%DMSO controls. (B) Djinx1 expression 
level in chelidonine-treated planarians (CH) and DMSO 0.1%controls. Expression 
levels are indicated in relative units, assuming a value of 1 for DMSO-treated 
controls. Samples were compared using the Kruskal-Wallis non-parametric ANOVA. 
*P<0.05. 
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Video S1: A representative example of a „curled‟ planarian fragment, as produced by 
20M chelidonine treatment. A small blastema, with a blister, is barely visible at the 
anterior region, 3 days after amputation (600 frames, 66.7 ms per frame). 
 
Video S2:  A representative example of a 0.1% DMSO regenerating control planarian 
is shown for comparison. Blastema is visible as a white area at the anterior region, 3 
days after amputation  (510 frames, 66.7 ms per frame). 
 
 
